Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Gland Pharma Ltd. ( (IN:GLAND) ) has issued an announcement.
Gland Pharma Limited has announced the appointment of M/s. RVR & Associates as the Secretarial Auditors for a term of five years, following approval at the company’s 47th Annual General Meeting. This strategic appointment is expected to enhance the company’s compliance management and corporate governance, potentially strengthening its market position and stakeholder confidence.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of complex injectables. The company is known for its robust portfolio of products and its commitment to quality and innovation in the healthcare sector.
Average Trading Volume: 8,931
Technical Sentiment Signal: Buy
Current Market Cap: 317.7B INR
Find detailed analytics on GLAND stock on TipRanks’ Stock Analysis page.